Inflammatory loops in the epithelial-immune microenvironment of the skin and skin appendages in chronic inflammatory diseases.

Teruki Dainichi, Masashi Iwata
Author Information
  1. Teruki Dainichi: Department of Dermatology, Kagawa University Faculty of Medicine, Kagawa, Japan.
  2. Masashi Iwata: Department of Dermatology, Kagawa University Faculty of Medicine, Kagawa, Japan.

Abstract

The epithelial-immune microenvironment (EIME) of epithelial tissues has five common elements: (1) microbial flora, (2) barrier, (3) epithelial cells, (4) immune cells, and (5) peripheral nerve endings. EIME provides both constant defense and situation-specific protective responses through three-layered mechanisms comprising barriers, innate immunity, and acquired immunity. The skin is one of the largest organs in the host defense system. The interactions between the five EIME elements of the skin protect against external dangers from the environment. This dysregulation can result in the generation of inflammatory loops in chronic inflammatory skin diseases. Here, we propose an understanding of EIME in chronic skin diseases, such as atopic dermatitis, psoriasis, systemic lupus erythematosus, alopecia areata, and acne vulgaris. We discuss the current treatment strategies targeting their inflammatory loops and propose possible therapeutic targets in the future.

Keywords

References

  1. Lancet. 2019 Jun 8;393(10188):2344-2358 [PMID: 31180031]
  2. J Autoimmun. 2020 Mar;108:102391 [PMID: 31883828]
  3. Sci Immunol. 2021 Jan 22;6(55): [PMID: 33483337]
  4. Rheumatol Int. 2021 Feb;41(2):355-360 [PMID: 32488429]
  5. Nat Rev Drug Discov. 2022 Jan;21(1):21-40 [PMID: 34417579]
  6. JCI Insight. 2018 Aug 9;3(15): [PMID: 30089718]
  7. Sci Transl Med. 2022 Apr 27;14(642):eabn2263 [PMID: 35476593]
  8. J Am Acad Dermatol. 2016 Jul;75(1):220-2 [PMID: 27317522]
  9. Microorganisms. 2022 Apr 21;10(5): [PMID: 35630309]
  10. Eur J Dermatol. 2002 Sep-Oct;12(5):422-7 [PMID: 12370127]
  11. Nat Commun. 2014;5:2870 [PMID: 24399259]
  12. Nat Rev Immunol. 2021 Nov;21(11):739-751 [PMID: 33846604]
  13. J Invest Dermatol. 1975 Oct;65(4):382-4 [PMID: 126263]
  14. Lupus. 2021 Sep;30(10):1553-1564 [PMID: 34139926]
  15. Nature. 2018 Aug;560(7720):649-654 [PMID: 30135581]
  16. Cell. 2021 Jan 21;184(2):294-296 [PMID: 33482094]
  17. Sci Immunol. 2022 Jul 22;7(73):eabo2787 [PMID: 35867799]
  18. Nat Commun. 2018 Dec 12;9(1):5075 [PMID: 30542056]
  19. JAMA Dermatol. 2017 May 1;153(5):406-412 [PMID: 28249066]
  20. J Invest Dermatol. 2013 Sep;133(9):2152-60 [PMID: 23337890]
  21. Front Immunol. 2019 Oct 09;10:2342 [PMID: 31649667]
  22. J Allergy Clin Immunol. 2024 Apr;153(4):879-893 [PMID: 37634890]
  23. Nat Med. 2014 Sep;20(9):1043-9 [PMID: 25129481]
  24. J Am Acad Dermatol. 2016 Dec;75(6):1265-1267 [PMID: 27846955]
  25. Immunity. 2015 Sep 15;43(3):515-26 [PMID: 26377898]
  26. J Am Acad Dermatol. 2022 Feb;86(2):406-413 [PMID: 34246698]
  27. J Invest Dermatol. 2003 Jul;121(1):20-7 [PMID: 12839559]
  28. J Dermatol Sci. 2014 Nov;76(2):81-9 [PMID: 25242498]
  29. J Am Acad Dermatol. 1986 Feb;14(2 Pt 1):221-5 [PMID: 2936775]
  30. J Allergy Clin Immunol. 2019 Oct;144(4):1036-1049 [PMID: 31378305]
  31. Int J Trichology. 2019 Jan-Feb;11(1):26-30 [PMID: 30820130]
  32. J Clin Invest. 2021 Feb 1;131(3): [PMID: 33529160]
  33. Nat Immunol. 2020 Jun;21(6):605-614 [PMID: 32367037]
  34. J Invest Dermatol. 2024 Jan;144(1):165-170.e5 [PMID: 37543243]
  35. J Allergy Clin Immunol. 2018 Sep;142(3):844-856 [PMID: 29155150]
  36. Br J Dermatol. 2018 Nov;179(5):1033-1048 [PMID: 29791718]
  37. Nature. 2017 Oct 26;550(7677):475-480 [PMID: 29045388]
  38. J Am Acad Dermatol. 2016 Jul;75(1):155-62 [PMID: 27061046]
  39. Clin Exp Rheumatol. 2015 Mar-Apr;33(2):166-73 [PMID: 25602442]
  40. J Invest Dermatol. 2017 Jan;137(1):18-25 [PMID: 27771048]
  41. Cell. 2021 Jan 21;184(2):422-440.e17 [PMID: 33450207]
  42. J Eur Acad Dermatol Venereol. 2023 Apr;37(4):666-679 [PMID: 36478475]
  43. Sci Rep. 2021 Aug 16;11(1):16591 [PMID: 34400712]
  44. Nat Commun. 2014 Jun 13;5:4020 [PMID: 24927181]
  45. J Allergy Clin Immunol. 2021 Aug;148(2):473-485.e10 [PMID: 33713763]
  46. Dermatol Ther. 2020 Jul;33(4):e13718 [PMID: 32472615]
  47. N Engl J Med. 2020 Jan 16;382(3):211-221 [PMID: 31851795]
  48. Nature. 2022 May;605(7909):349-356 [PMID: 35477763]
  49. Sci Immunol. 2022 Oct 28;7(76):eabm9811 [PMID: 36306369]
  50. Sci Transl Med. 2018 Aug 15;10(454): [PMID: 30111646]
  51. Front Immunol. 2019 May 16;10:1107 [PMID: 31156649]
  52. J Dermatol Sci. 2017 Apr;86(1):3-12 [PMID: 27765435]
  53. Arthritis Rheumatol. 2014 Mar;66(3):694-706 [PMID: 24574230]
  54. Sci Transl Med. 2022 Feb 16;14(632):eabh1478 [PMID: 35171653]
  55. JAMA. 2021 Nov 23;326(20):2055-2067 [PMID: 34812859]
  56. J Allergy Clin Immunol. 2018 May;141(5):1677-1689.e8 [PMID: 29427643]
  57. Front Physiol. 2022 Jun 21;13:921866 [PMID: 35800343]
  58. Clin Exp Dermatol. 2007 Nov;32(6):650-3 [PMID: 17725664]
  59. Nat Rev Immunol. 2023 Jan;23(1):9-23 [PMID: 35534624]
  60. J Invest Dermatol. 2006 Nov;126(11):2430-7 [PMID: 16778793]
  61. Front Immunol. 2022 Aug 30;13:955035 [PMID: 36110853]
  62. Acta Derm Venereol. 2012 May;92(3):241-6 [PMID: 22678562]
  63. Nat Immunol. 2018 Dec;19(12):1286-1298 [PMID: 30446754]
  64. Arthritis Rheumatol. 2020 Jan;72(1):67-77 [PMID: 31390162]
  65. Nat Rev Dis Primers. 2017 Mar 16;3:17011 [PMID: 28300084]
  66. Nature. 2010 Jul 1;466(7302):113-7 [PMID: 20596022]
  67. Cell. 2023 Feb 2;186(3):607-620.e17 [PMID: 36640762]
  68. Nat Rev Dis Primers. 2018 Jun 21;4(1):1 [PMID: 29930242]
  69. Nat Immunol. 2017 Jun 20;18(7):716-724 [PMID: 28632714]
  70. Nat Rev Dis Primers. 2016 Nov 24;2:16082 [PMID: 27883001]
  71. Nat Rev Dis Primers. 2015 Sep 17;1:15029 [PMID: 27189872]
  72. J Invest Dermatol. 2017 Jun;137(6):1213-1214 [PMID: 28395897]
  73. Nature. 2019 Nov;575(7782):366-370 [PMID: 31546246]
  74. Nat Rev Rheumatol. 2016 Nov 22;12(12):716-730 [PMID: 27872476]

MeSH Term

Humans
Skin
Psoriasis
Skin Diseases
Dermatitis, Atopic
Epithelium

Word Cloud

Created with Highcharts 10.0.0skinEIMEinflammatoryloopschronicdiseasesepithelial-immunemicroenvironmentepithelialfivecellsdefenseimmunityproposeatopicdermatitispsoriasissystemiclupuserythematosusalopeciaareataacnetissuescommonelements:1microbialflora2barrier34immune5peripheralnerveendingsprovidesconstantsituation-specificprotectiveresponsesthree-layeredmechanismscomprisingbarriersinnateacquiredonelargestorganshostsysteminteractionselementsprotectexternaldangersenvironmentdysregulationcanresultgenerationunderstandingvulgarisdiscusscurrenttreatmentstrategiestargetingpossibletherapeutictargetsfutureInflammatoryappendages

Similar Articles

Cited By